Belize vs Republic of Moldova: Access to anti-retroviral drugs, male
Belize
48.0%
in 2024
Republic of Moldova
47.0%
in 2024
Belize rank
120th
Republic of Moldova rank
122nd
Access to anti-retroviral drugs, male over time
- Belize
- Republic of Moldova
How they compare
Belize currently reports 48.0% against 47.0% in Republic of Moldova, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Republic of Moldova ahead.
Belize ranks 120th and Republic of Moldova ranks 122nd of 141 countries.
Belize has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.9% | 1.4% | 7.5% | Belize |
| 2010s | 30.8% | 16.0% | 14.8% | Belize |
| 2020s | 42.2% | 39.2% | 3.0% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Belize or Republic of Moldova?
- Belize, at 48.0% against 47.0% in Republic of Moldova as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Belize and Republic of Moldova?
- 1.0%, with Belize ahead.
- How many years of comparable data are there for Belize and Republic of Moldova?
- 25 years are reported by both, from 2000 to 2024.
- How do Belize and Republic of Moldova rank globally for access to anti-retroviral drugs, male?
- Belize ranks 120th and Republic of Moldova ranks 122nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.